216 related articles for article (PubMed ID: 11320680)
1. Who develops severe or fatal adverse drug reactions to selective serotonin reuptake inhibitors?
Dalfen AK; Stewart DE
Can J Psychiatry; 2001 Apr; 46(3):258-63. PubMed ID: 11320680
[TBL] [Abstract][Full Text] [Related]
2. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.
Isbister GK; Bowe SJ; Dawson A; Whyte IM
J Toxicol Clin Toxicol; 2004; 42(3):277-85. PubMed ID: 15362595
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors.
Ekhart C; van Hunsel F; Scholl J; de Vries S; van Puijenbroek E
Drug Saf; 2018 Jul; 41(7):677-683. PubMed ID: 29484612
[TBL] [Abstract][Full Text] [Related]
4. SSRI safety in overdose.
Barbey JT; Roose SP
J Clin Psychiatry; 1998; 59 Suppl 15():42-8. PubMed ID: 9786310
[TBL] [Abstract][Full Text] [Related]
5. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP.
Degner D; Grohmann R; Kropp S; Rüther E; Bender S; Engel RR; Schmidt LG
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S39-45. PubMed ID: 15052513
[TBL] [Abstract][Full Text] [Related]
6. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).
Hedenmalm K; Sundström A; Spigset O
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):719-25. PubMed ID: 16783834
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.
Spindelegger CJ; Papageorgiou K; Grohmann R; Engel R; Greil W; Konstantinidis A; Agelink MW; Bleich S; Ruether E; Toto S; Kasper S
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522416
[TBL] [Abstract][Full Text] [Related]
8. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
Whyte IM; Dawson AH; Buckley NA
QJM; 2003 May; 96(5):369-74. PubMed ID: 12702786
[TBL] [Abstract][Full Text] [Related]
9. Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders.
Kling A; Danell-Boman M; Stenlund H; Dahlqvist R
Arthritis Rheum; 2009 Oct; 61(10):1322-7. PubMed ID: 19790123
[TBL] [Abstract][Full Text] [Related]
10. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.
Pariente A; Daveluy A; Laribière-Bénard A; Miremont-Salame G; Begaud B; Moore N
Drug Saf; 2009; 32(5):441-7. PubMed ID: 19419238
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of antidepressant drugs: updated.
Glassman AH
J Clin Psychiatry; 1998; 59 Suppl 15():13-8. PubMed ID: 9786306
[TBL] [Abstract][Full Text] [Related]
12. Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database.
Valeiro C; Matos C; Scholl J; van Hunsel F
Drug Saf; 2022 Jun; 45(6):639-650. PubMed ID: 35386045
[TBL] [Abstract][Full Text] [Related]
13. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.
Aagaard L; Hansen EH
BMC Clin Pharmacol; 2009 Mar; 9():4. PubMed ID: 19254390
[TBL] [Abstract][Full Text] [Related]
14. Optimizing drug selection in psychopharmacology based on 40 significant CYP2C19- and CYP2D6-biased adverse drug reactions of selective serotonin reuptake inhibitors.
Eugene AR
PeerJ; 2019; 7():e7860. PubMed ID: 31616600
[TBL] [Abstract][Full Text] [Related]
15. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
Machado M; Iskedjian M; Ruiz I; Einarson TR
Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000.
Cheeta S; Schifano F; Oyefeso A; Webb L; Ghodse AH
Br J Psychiatry; 2004 Jan; 184():41-7. PubMed ID: 14702226
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant toxicity and the need for identification and concentration monitoring in overdose.
Power BM; Hackett LP; Dusci LJ; Ilett KF
Clin Pharmacokinet; 1995 Sep; 29(3):154-71. PubMed ID: 8521678
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
[TBL] [Abstract][Full Text] [Related]
19. A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India.
Lucca JM; Madhan R; Gurumurthy P; Dushad R
Indian J Pharmacol; 2014; 46(5):543-6. PubMed ID: 25298586
[TBL] [Abstract][Full Text] [Related]
20. Citalopram Overdose: a Fatal Case.
Kraai EP; Seifert SA
J Med Toxicol; 2015 Jun; 11(2):232-6. PubMed ID: 25326372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
